FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma

Journal:

Nature Communications

Published:

2025-05-22

DOI:

10.1038/s41467-025-59971-0

Affiliations:

12

Authors:

22

Go to article

Institutions	Authors	Share
University of Zurich (UZH), Switzerland	10.000000 10.000000	0.45
Department of Biomedicine Basel, Switzerland	4.500000	0.20
InCephalo AG, Switzerland	2.500000	0.11
Zurich University of Applied Sciences (ZHAW), Switzerland	2.000000	0.09
University Hospital Basel (USB), UB, Switzerland	1.000000	0.05
University of Southampton (Soton), United Kingdom (UK)	1.000000	0.05
University of California, San Francisco (UCSF), United States of America (USA)	0.500000	0.02
Parker Institute for Cancer Immunotherapy, United States of America (USA)	0.500000	0.02

Interested in Oncology and Carcinogenesis?